UK markets closed

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.5596+0.0362 (+6.92%)
As of 12:14PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8888
Avg. Estimate-0.14-0.13-0.5-0.27
Low estimate-0.21-0.2-0.77-0.64
High estimate-0.08-0.08-0.230.28
Year ago EPS-0.66-0.59-1.48-0.5
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6678
Avg. Estimate8.24M7.58M45.88M79.01M
Low estimate2M2M13.8M26.4M
High estimate17.8M13.1M95M229M
Year ago sales14.83M10.4M176.23M45.88M
Sales growth (year/est)-44.40%-27.10%-74.00%72.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.34-0.32-0.26-0.21
Actual EPS-0.66-0.59-0.34-0.27
Difference-0.32-0.27-0.08-0.06
Surprise %-94.10%-84.40%-30.80%-28.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.14-0.13-0.5-0.27
7 days ago-0.14-0.13-0.5-0.27
30 days ago-0.14-0.13-0.5-0.27
60 days ago-0.1-0.1-0.48-0.48
90 days ago-0.1-0.1-0.48-0.48
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSGMOIndustrySector(s)S&P 500
Current qtr.78.80%N/AN/AN/A
Next qtr.78.00%N/AN/AN/A
Current year66.20%N/AN/AN/A
Next year46.00%N/AN/AN/A
Next 5 years (per annum)-17.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A